Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0L5FB
|
|||
| Former ID |
DNCL002924
|
|||
| Drug Name |
TAK-329
|
|||
| Indication | Diabetic complication [ICD-11: 5A2Y; ICD-9: 253.5, 588.1] | Phase 1 | [1] | |
| Company |
Takeda Pharmaceuticals U.S.A.
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01311076) TAK-329 Glucose Clamp Study. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Takeda. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.